Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 of Bupivacaine for Interscalene Block
NCT07338916Completed
- Sponsor
- Hospital del Trabajador
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bupivacaine in shoulder surgery, sponsored by Hospital del Trabajador. Primary endpoint: Minimum Effective Volume (MEV90) for Supraclavicular Nerve Block via Interscalene Approach. Started Apr 2026; status: completed.
02
Drugs
bupivacaine
03
Conditions
shoulder surgery
Beyond the preview
Go deeper on NCT07338916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338916.